Treatment for children is more cautious, mainly to avoid affecting growth and development. Commonly used are topical glucocorticoids, mydriatics and nonsteroidal anti-inflammatory drugs; chronic or difficult cases will use methotrexate or immunosuppressants or biologics like Humira to reduce long-term steroid use. Treatment requires multidisciplinary cooperation between ophthalmology and rheumatology, and close monitoring of the child’s growth and development.